Jason Bednar
Stock Analyst at Piper Sandler
(2.30)
# 2,388
Out of 4,814 analysts
163
Total ratings
37.88%
Success rate
-3.25%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Maintains: Overweight | $5 → $4.5 | $1.38 | +226.09% | 3 | Mar 28, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $270 → $235 | $171.41 | +37.10% | 29 | Mar 18, 2025 | |
| COO The Cooper Companies | Reiterates: Overweight | $120 → $115 | $79.55 | +44.56% | 12 | Mar 7, 2025 | |
| SOLV Solventum | Maintains: Neutral | $75 → $84 | $65.70 | +27.85% | 3 | Feb 28, 2025 | |
| MASI Masimo | Maintains: Overweight | $210 → $215 | $152.40 | +41.08% | 14 | Feb 26, 2025 | |
| KRMD KORU Medical Systems | Downgrades: Neutral | $4.5 | $2.26 | +99.56% | 6 | Feb 14, 2025 | |
| STE STERIS | Maintains: Overweight | $260 → $265 | $220.02 | +20.44% | 9 | Feb 3, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $17 → $18 | $15.19 | +18.50% | 11 | Feb 3, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Overweight | $114 → $116 | $90.82 | +27.73% | 9 | Jan 29, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $275 → $280 | $200.40 | +39.72% | 7 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $42 | $15.56 | +169.92% | 9 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $24 | $31.33 | -23.40% | 9 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $1.58 | +280.95% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $2.59 | +169.86% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.24 | +317.36% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $12 | $4.55 | +163.74% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $86 | $64.28 | +33.79% | 6 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $13 | $10.47 | +24.16% | 1 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $35 → $32 | $12.84 | +149.22% | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $482.40 | -22.89% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $62.37 | +52.32% | 1 | Apr 19, 2023 |
EDAP TMS
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $1.38
Upside: +226.09%
Align Technology
Mar 18, 2025
Reiterates: Overweight
Price Target: $270 → $235
Current: $171.41
Upside: +37.10%
The Cooper Companies
Mar 7, 2025
Reiterates: Overweight
Price Target: $120 → $115
Current: $79.55
Upside: +44.56%
Solventum
Feb 28, 2025
Maintains: Neutral
Price Target: $75 → $84
Current: $65.70
Upside: +27.85%
Masimo
Feb 26, 2025
Maintains: Overweight
Price Target: $210 → $215
Current: $152.40
Upside: +41.08%
KORU Medical Systems
Feb 14, 2025
Downgrades: Neutral
Price Target: $4.5
Current: $2.26
Upside: +99.56%
STERIS
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $220.02
Upside: +20.44%
Envista Holdings
Feb 3, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $15.19
Upside: +18.50%
Merit Medical Systems
Jan 29, 2025
Reiterates: Overweight
Price Target: $114 → $116
Current: $90.82
Upside: +27.73%
Becton, Dickinson and Company
Jan 28, 2025
Maintains: Overweight
Price Target: $275 → $280
Current: $200.40
Upside: +39.72%
Dec 13, 2024
Maintains: Overweight
Price Target: $28 → $42
Current: $15.56
Upside: +169.92%
Dec 6, 2024
Maintains: Neutral
Price Target: $26 → $24
Current: $31.33
Upside: -23.40%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $1.58
Upside: +280.95%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $2.59
Upside: +169.86%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.24
Upside: +317.36%
Aug 1, 2024
Maintains: Overweight
Price Target: $14 → $12
Current: $4.55
Upside: +163.74%
Jun 21, 2024
Reiterates: Overweight
Price Target: $86
Current: $64.28
Upside: +33.79%
May 21, 2024
Initiates: Neutral
Price Target: $13
Current: $10.47
Upside: +24.16%
May 3, 2024
Reiterates: Neutral
Price Target: $35 → $32
Current: $12.84
Upside: +149.22%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $482.40
Upside: -22.89%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $62.37
Upside: +52.32%